All Stories

  1. A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and CTLA4-Mediated Immune Dysregulation Syndrome in Greece
  2. A Nationwide Study of the Delayed Diagnosis and the Clinical Manifestations of Predominantly Antibody Deficiencies and CTLA4-Mediated Immune Dysregulation Syndrome in Greece
  3. Hereditary Carboxypeptidase N deficiency, a clinical situation presenting with urticaria and angioedema
  4. Identification of the novel HLA‐DRB1*11:308 allele in a Greek individual
  5. Leveraging Genetics for Hereditary Angioedema: A Road Map to Precision Medicine
  6. Deep Intronic SERPING1 Gene Variants: Ending One Odyssey and Starting Another?
  7. A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency
  8. Plasminogen glycoforms alteration and activation susceptibility associated with the missense variant p.Lys330Glu in HAE‐PLG patients
  9. International Consensus on the Use of Genetics in the Management of Hereditary Angioedema
  10. TNFRSF13C/BAFFR P21R and H159Y polymorphisms in multiple sclerosis
  11. Driving towards Precision Medicine for angioedema without wheals
  12. BAFF/APRIL System Is Functional in B-Cell Acute Lymphoblastic Leukemia in a Disease Subtype Manner
  13. The role of the NLRP3 inflammasome and the activation of IL-1β in the pathogenesis of chronic viral hepatic inflammation
  14. Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency
  15. On the pathogenicity of the plasminogen K330E mutation for hereditary angioedema
  16. Novel SERPING1 mutations in bulgarian patients revealed by a targeted next generation sequencing platform
  17. Novel pathogenic GLA mutations revealed in a Greek population study for Fabry disease
  18. The D313Y mutation of the GLA gene could be pathogenic for Fabry disease
  19. An Activating Janus Kinase-3 Mutation Is Associated with Cytotoxic T Lymphocyte Antigen-4-Dependent Immune Dysregulation Syndrome
  20. Fabry disease due to D313Y and novel GLA mutations
  21. Families presenting with Carboxypeptidase N deficiency, 37 years after the single description
  22. Type I interferonopathy in a young adult
  23. Hereditary Angioedema with Normal C1 Inhibitor
  24. 07.13 A case of sting-associated vasculopathy with onset in infancy (savi) in a young adult male with a novel tmem173 gene mutation
  25. SIAE Rare Variants in Juvenile Idiopathic Arthritis and Primary Antibody Deficiencies
  26. Genetic Determinants of C1 Inhibitor Deficiency Angioedema Age of Onset
  27. Screening of the Greek population for Fabry disease via pedigree analysis
  28. The NLRP3 inflammasome is activated in liver tissue of patients with newly diagnosed chronic hepatitis B virus infection
  29. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis
  30. Association between TLR2/TLR4 gene polymorphisms and COPD phenotype in a Greek cohort
  31. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency
  32. Genetics of Hereditary Angioedema Revisited
  33. TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment
  34. Survivin Autoantibodies Are Not Elevated in Lung Cancer When Assayed Controlling for Specificity and Smoking Status
  35. Atomic Coordination Reflects Peptide Immunogenicity
  36. The coordination of unprotonated peptide tertiary structure as a metric of pMHC–TCR functional avidity
  37. Human Cytomegalovirus variant peptides adapt by decreasing their total coordination upon binding to a T cell receptor
  38. F12-46C/T and hereditary angioedema severity
  39. The quantum chemical causality of pMHC-TCR biological avidity: Peptide atomic coordination data and the electronic state of agonist N termini
  40. Genetic polymorphisms of innate and adaptive immunity as predictors of outcome in critically ill patients
  41. Quantum chemical calculations predict biological function
  42. Hereditary angioedema: Molecular and clinical differences among European populations
  43. MBL2Genotypes and Their Associations with MBL Levels and NICU Morbidity in a Cohort of Greek Neonates
  44. Impaired degradation and aberrant phagocytosis of necrotic cell debris in the peripheral blood of patients with primary Sjögren's syndrome
  45. TACI Expression and Signaling in Chronic Lymphocytic Leukemia
  46. Hereditary Hyperferritinemia Cataract Syndrome as a Cause of Childhood Hyperferritinemia
  47. A common single nucleotide polymorphism impairs B-cell activating factor receptor's multimerization, contributing to common variable immunodeficiency
  48. Hereditary Angioedema in Greece: The First Results of the Greek Hereditary Angioedema Registry
  49. Fast Detection Of MYD88-L265P Mutation By PCR-RFLP In Chronic Lymphoproliferative Disorders
  50. Rapid detection of MYD88-L265P mutation by PCR-RFLP in B-cell lymphoproliferative disorders
  51. Reply to: “SLC40A1-R178G or R178Q and ferroportin disease? A call for vigilance in mutation reporting”
  52. Corrigendum to: Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV [Blood Cells Mol. Dis. 40:3 (2008) 353–359]
  53. Allergy and risk of acute lymphoblastic leukemia among children: A nationwide case control study in Greece
  54. Heterozygous Alterations of TNFRSF13B/TACI in Tonsillar Hypertrophy and Sarcoidosis
  55. Liver FOXP3 and PD1/PDL1 Expression is Down-Regulated in Chronic HBV Hepatitis on Maintained Remission Related to the Degree of Inflammation
  56. C0176 Influence of common thrombophilia polymorphisms on the thrombosis risk in patients with JAK2-V617F-positive myeloproliferative neoplasms
  57. IgA antibodies against deamidated gliadin peptides in patients with chronic liver diseases
  58. Expression patterns of endothelin-1 and its receptors in colorectal cancer
  59. Neutrophil gelatinase-associated lipocalin (NGAL) in inflammatory bowel disease: association with pathophysiology of inflammation, established markers, and disease activity
  60. CLINICAL SIGNIFICANCE OF DEAMIDATED GLIADIN PEPTIDE ANTIBODIES IN PATIENTS WITH CHRONIC LIVER DISEASES
  61. SLC40A1-R178G mutation and ferroportin disease
  62. TNFRSF13B/TACI Alterations in Greek Patients with Antibody Deficiencies
  63. Survivin isoform expression patterns in CML patients correlate with resistance to imatinib and progression, but do not trigger cytolytic responses
  64. Foxp3Expression in Liver Correlates with the Degree but Not the Cause of Inflammation
  65. Toll-Like Receptor 4 Gene (TLR4), but NotTLR2, Polymorphisms Modify the Risk of Tonsillar Disease Due toStreptococcus pyogenesandHaemophilus influenzae
  66. Determinants of cancer immunotherapy success
  67. Downregulation of serum epidermal growth factor in patients with inflammatory bowel disease. Is there a link with mucosal damage?
  68. Cord blood as a source of non-senescent lymphocytes for tumor immunotherapy
  69. 612 LIVER PD-1/PDL-1/PD-L2 MRNA EXPRESSION QUANTITATIVE ANALYSIS IN PATIENTS WITH CHRONIC HBV AND HCV HEPATITIS
  70. Naturally occurring tumor-specific CD8+ T-cell precursors in individuals with and without cancer
  71. Cytolytic T-cell response against Epstein-Barr virus in lung cancer patients and healthy subjects
  72. Absence of aprataxin gene mutations in a Greek cohort with sporadic early onset ataxia and normal GAA triplets in frataxin gene
  73. Hereditary angioedema in Greek families caused by novel and recurrent mutations
  74. Anti-survivin antibody responses in lung cancer
  75. TLR2 and TLR4 polymorphisms in familial Mediterranean fever
  76. Cord blood lymphocytes combating immunosenescence
  77. Clinical, functional and biochemical changes during recovery from COPD exacerbations
  78. Association of TLR4-T399I Polymorphism with Chronic Obstructive Pulmonary Disease in Smokers
  79. Imbalance of tissue inhibitors of metalloproteinases (TIMP) – 1 and – 4 serum levels, in patients with inflammatory bowel disease
  80. Baseline levels of CD8+ T cells against survivin and survivin-2B in the blood of lung cancer patients and cancer-free individuals
  81. The effect of blood transfusion on 51Cr-red blood cells surface-counting data in homozygous β-thalassaemia
  82. Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV
  83. Co-expression patterns of tumor-associated antigen genes by non-small cell lung carcinomas: Implications for immunotherapy
  84. Adiponectin: A New Independent Predictor of Liver Steatosis and Response to IFN-α Treatment in Chronic Hepatitis C
  85. Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis
  86. TLR4 single nucleotide polymorphisms and thrombosis risk in patients with myeloproliferative disorders
  87. Immunological features of visceral leishmaniasis may mimic systemic lupus erythematosus
  88. Foxp3 expression in human cancer cells
  89. Prevalence of coeliac disease in the adult population of central Greece
  90. Tumor immune escape mediated by indoleamine 2,3-dioxygenase
  91. Indoleamine 2,3-dioxygenase (IDO) expression in lung cancer
  92. Acute phase markers for the differentiation of infectious and malignant pleural effusions
  93. Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis
  94. DHLAS: A web-based information system for statistical genetic analysis of HLA population data
  95. A Brief Exposure to Moderate Passive Smoke Increases Metabolism and Thyroid Hormone Secretion
  96. Diagnostic value of anticyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis: association with extra-articular manifestations
  97. Immunoepigenetics: the unseen side of cancer immunoediting
  98. Leptin Receptor Isoforms mRNA Expression in Peripheral Blood Mononuclear Cells from Patients with Chronic Viral Hepatitis
  99. Alterations of leptin during IFN-α therapy in patients with chronic viral hepatitis
  100. Cytokine levels in the sera of patients with idiopathic pulmonary fibrosis
  101. Performance of Antibodies against Tissue Transglutaminase for the Diagnosis of Celiac Disease: Meta-Analysis
  102. Morning Levels of C-Reactive Protein in Children with Obstructive Sleep-disordered Breathing
  103. Complement: An Inflammatory Pathway Fulfilling Multiple Roles at the Interface of Innate Immunity and Development
  104. Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension
  105. Morning levels of fibrinogen in children with sleep-disordered breathing
  106. Soluble adhesion molecules are not involved in the development of retinopathy in type 2 diabetic patients
  107. Evaluation of a Microsphere‐Based Flow Cytometric Assay for Diagnosis of Celiac Disease
  108. IN VIVO EFFECT OF rhGM-CSF AND rhG-CSF ON MONOCYTE HLA-DR EXPRESSION OF SEPTIC NEONATES
  109. STL3/433: IATROTEK On-line: The Hellenic medical literature retrieval system
  110. Nationwide collaborative study of HLA class II associations with distinct types of juvenile chronic arthritis (JCA) in Greece
  111. THE MONOCYTE HLA-DR EXPRESSION OF HEALTHY AND INFECTED PREMATURE NEONATES
  112. The Monocyte HLA-DR Expression of Healthy and Infected Premature Neonates
  113. Beyond the Ingelfinger Rule: the intellectual property ethics after the end of biomedical journals' monopoly
  114. Non-indexed medical journals in the Web: new perspectives in the medical literature
  115. Common allelic combinations in greek population
  116. Evaluation of a simplified anti-human globulin augmented cytotoxicity technique
  117. Prediction of acceptable mismatches based on the detection of patients' CREGs
  118. Standardization of the collection methodology for the establishment of a placental/cord blood (PCB) bank
  119. Highly sensitized patients would be easier transplanted only by the assignment of their HLA-antigens in CREGs
  120. THE IMMUNOMODULATORY EFFECT OF LEFLUNOMIDE IN RAT CARDIAC ALLOTRANSPLANTATION
  121. Concentrations of main serum opsonins in early infancy.
  122. Serum Protein Markers (Hp, GC, C3) in Patients with Colon Cancer
  123. Serum Protein Groups (Hp, GC, C3) in Patients with Gastric Carcinoma
  124. Kinetics of heat-damaged homologous erythrocytes
  125. Thalassemic Patients Are at High Risk for Transfusion-Transmitted Cytomegalovirus Infections
  126. Function of reticuloendothelial system in splenectomised thalassemics
  127. Assessment of splenic and RES function of patients with thalassemia major long after partial splenic embolization: In vivo clearance study
  128. Partial splenic embolisation for hypersplenism of thalassaemia major: five year follow up.
  129. C3 Polymorphism in Greece
  130. Plasma fibronectin (Fn) study in homozygous ?-thalassemia: Relation to splenectomy and transfusion
  131. Genetic Markers in Renal Adenocarcinoma
  132. C3 Polymorphism in Beta-Thalassemia
  133. Group-Specific Component and Haptoglobin Phenotypes in Multiple Myeloma
  134. A Simultaneous Study of the Polymorphism of Five Proteins in the Serum and the Urine of Nephrotic Patients
  135. Rapid Phenotyping of C3 by Immunofixation on Cellulose Acetate Strips
  136. Serum Alpha-1-Antitrypsin Study in Beta-Thalassaemic Patients